Primary Sclerosing Cholangitis in the Absence of Inflammatory Bowel Disease Increases the Risk of Colorectal Cancer: A Multi‐Centre Propensity Score Matched Analysis
Our findings provide real-world evidence that PSC is an independent risk factor for colorectal cancer, even in the absence of concomitant IBD. These results support the need for further research to determine whether patients with isolated PSC may benefit from tailored CRC surveillance strategies.
Authors
- Adam S. Faye (ORCID: https://orcid.org/0000-0002-1571-5856)
- Aasma Shaukat
- Mohammad Bilal (ORCID: https://orcid.org/0000-0002-1784-212X)
- Razan Aburumman (ORCID: https://orcid.org/0000-0003-1559-7893)
- Saqr Alsakarneh (ORCID: https://orcid.org/0000-0002-8776-2176)
- Jana G. Hashash (ORCID: https://orcid.org/0000-0001-8305-9742)
Institutions
- Mayo Clinic (US)
- City University of New York (US)
- Jacksonville College (US)
- WinnMed (US)
- Mayo Clinic in Florida (US)
- University of Colorado Denver (US)
Publication Details
- Journal
- Alimentary Pharmacology & Therapeutics
- Published
- 2025-07-24
- DOI
- https://doi.org/10.1111/apt.70303
- Citations
- 3
- Primary Topic
- Liver Diseases and Immunity
- Type
- article
- Field-Weighted Citation Impact
- 3.97